Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00169936 · ClinicalTrials.gov registry record · Phase 3
Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients
A Phase 3 study of Heart Transplantation, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 3
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT00169936: Completed Phase 3 study of Heart Transplantation, sponsored by Mayo Clinic.
NCT00169936 is a Phase 3 study of Heart Transplantation that has completed, run by Mayo Clinic. The registered enrollment target is 6 participants, below the 590-participant average among 4 other Heart Transplantation trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00169936, a Phase 3 study of Heart Transplantation, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
Heart transplantation is a great procedure for selected patients with end-stage heart failure, but graft rejection remains a major factor limiting long-term survival despite continued advancement in the scientific skill of immunosuppression. The only reliable method used today to detect rejection is doing repeated biopsy of the heart. This is expensive, invasive, inconvenient to the patient, and associated with a significant risk of serious complications, as a piece directly from the inner surface of the patients heart is needed. The magnetocardiograph (MCG) device is an invention that may provide new means to assess changes in the heart tissue, as it may detect small changes that happen in the heart cells when they are undergoing rejection.
Conditions Studied
Interventions
- DEVICE Magnetocardiograph
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2004-12 |
| Est. Completion | 2007-01 |
| Phase | Phase 3 |
What the finished NCT00169936 record still lists
NCT00169936 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 590-participant average among 4 other Heart Transplantation trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Heart Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Magnetocardiograph is the first listed.
NCT00169936 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT00169936 about?
NCT00169936 is a clinical study titled "Magnetocardiography as a Non-Invasive Tool for Detecting Tissue Rejection in Heart Transplant Patients". Heart transplantation is a great procedure for selected patients with end-stage heart failure, but graft rejection remains a major factor limiting long-term survival despite continued advancement in the scientific skill of immunosuppression. The only reliable method used today to detect rejection is...
What is the current status of trial NCT00169936?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 6 participants. The study started on 2004-12. Estimated completion is 2007-01.
What conditions does trial NCT00169936 study?
This clinical trial studies the following conditions: Heart Transplantation.
What interventions are being tested in trial NCT00169936?
The interventions under investigation include: Magnetocardiograph (DEVICE).
Who is sponsoring clinical trial NCT00169936?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00169936 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients
COMPLETED · Phase 3
-
Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant
COMPLETED · Phase 3
-
Belatacept in De Novo Heart Transplantation
RECRUITING · Phase 2
-
Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia